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Abstract:  We investigated differences between healthy tissue and 
metastatic tumor from ex vivo human partial liver resections using diffuse 
optical spectroscopy with a fiber optic probe. We extracted various 
physiological and morphological parameters from the spectra. During 
evaluation of the residual between the measurements and a fit model based 
on diffusion theory, we found that bile is an additional chromophore 
absorbing in the visible wavelength range that was missing in our model. 
Consistency of the residual with the absorption spectrum of bile was 
noticed. An accurate measurement of the absorption coefficient of bile from 
various human bile samples was performed and implemented into the fit 
model. Having the absorption coefficient of bile as a priori knowledge in 
the model showed a clear improvement in terms of reducing the fitting 
discrepancies. The addition of this chromophore yields significantly 
different estimates of the amount of blood. Furthermore, the estimated bile 
volume fraction and reduced scattering amplitude turned out to be two main 
relevant discriminators between normal and metastatic liver tissues. 
©2011 Optical Society of America 
OCIS codes:  (170.6935) Tissue characterization; (300.6170) Spectra; (170.3660) Light 
propagation in tissues; (170.1610) Clinical applications. 
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1. Introduction 
Incidence and mortality rates of primary and secondary liver cancer have progressively 
increased worldwide over the last two decades [1]. In the western world, malignant lesions of 
the liver are generally metastases from other organs. Tumors of the gastro-intestinal tract, 
such as primary colorectal cancer, preferentially metastasize to the liver. 
For liver metastases of colorectal origin, resection is the only accepted treatment with 
curative intent. However, radiofrequency ablation (RFA) is an increasingly practiced 
treatment modality for patients with liver malignancy that are not suitable for surgery [2–4]. 
The main negative prognostic factor for survival after liver surgery is a positive surgical 
margin [5,6]. Histological analysis to determine the surgical margin is still considered to be 
the golden standard. However, intra-operative margin analysis would allow direct surgical 
intervention of a positive surgical margin, therefore reducing the chance of post-operative 
loco-regional recurrence. 
Patients treated with RFA have demonstrated prolonged survival compared to patients 
treated with chemotherapy alone [7,8]. Nevertheless, localization of the ablative needle and 
monitoring of the ablation process are important steps for optimal treatment of liver 
malignancies with RFA, since incidence of loco-regional disease recurrence due to ineffective 
ablation ranges from 3.6% to 60% [9]. Therefore, real-time intra-operative needle localization 
and ablation monitoring could improve ablation efficacy and disease-free survival. 
Diffuse optical spectroscopy with fiber optic probes is a widely used technique to estimate 
the optical properties of tissue [10–15]. Concomitantly, several models have been developed 
to extract the absorption and reduced scattering coefficients from the measured spectra which 
are subsequently converted into physiological parameters. Such parameters are very useful to 
discriminate between healthy tissue and tumors in different organs. Indeed, several ex vivo 
and in vivo clinical studies were performed in the last decade showing the potential of optical 
spectroscopy to discriminate between healthy and tumor samples. However, only a few 
studies have focused on estimating tissue optical properties from spectroscopy measurements 
in liver [16–18] compared to other organs such as breast [11,19–21], cervix [22,23], lung 
[10,24,25] and skin [26–28]. 
In the present paper, we report on an ex vivo clinical study of healthy and metastatic 
human liver tissue where we measured the diffuse optical spectra in the 500-1600 nm 
wavelength range. From the acquired spectra, several physiological and morphological 
parameters of clinical relevance were extracted, using a widely accepted analytical model 
developed by Farrell et al. based on the diffusion theory [29]. Recently, we have shown the 
applicability of the  model to wavelength ranges extended to 1600 nm where additional 
absorption features of water and lipids appear [30,31]. Parameters that were also obtained by 
fitting the model to the measurements are blood, water, lipid volume fractions, average vessel 
radius, oxygen saturation level in blood and tissue scattering properties. Accurate analysis of 
the measured spectra suggested that bile is an important chromophore in the liver because it 
significantly absorbs in the visible wavelength range. This chromophore should therefore be 
included in the fitting model. The difference between healthy and tumor ex vivo human liver 
tissue was investigated based upon the parameters extracted from these measurements. 
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2.1. Patients and liver tissue handling 
The presented pilot study on ex vivo liver was conducted at the Netherlands Cancer Institute in 
Amsterdam (NKI-AVL) under approval from the internal review board committee. Spectra 
were collected from liver surgical specimens after partial liver hepatectomy. Before resection 
of the specimen, the hepatic vessels that provide the blood supply to the part of the liver 
containing the tumor were clamped up to one hour before the resection started. Directly after 
resection, tissue was transported to the pathology department for further processing. After 
gross inspection by the pathologist, the optical spectra were collected from macroscopic 
normal and malignant tissue samples. Spectroscopy measurements were performed on freshly 
excised tissue before formalin fixation within two hours after the resection. In order to ensure 
that the measurements were at the tumor location, the samples were cut by the pathologist 
such that the tumor would be exposed in the most optimal way for measurements. All tumors 
were colorectal metastases and none were primary tumors. At the measurement sites, tissue 
was collected for conventional histopathology and the slides were analyzed at the pathology 
department. The pathological findings were correlated with the optical measurements. 
Several spectra were measured on liver tissues from 14 enrolled patients. In average, 15 
spectra at different sites were taken from each of the fourteen healthy and metastatic tumor 
samples, respectively. All the measurements taken from the 14 samples were included in the 
study and compiled with the results from the pathological report. All measurements were 
performed by the same operator and care was taken to ensure the same measuring conditions 
on all the samples. 
2.2. Instrumentation and calibration 
The spectra were collected from the different samples with an instrument which was used in 
our previous study [31]. The setup consists of a halogen broadband light source with an 
embedded shutter, an optical probe with three fibers and two spectrometers that can resolve 
light from 400 to 1100 nm (silicon detector) and 800 to 1700 nm (InGaAs detector), 
respectively. A filter that rejects light for wavelengths below 465 nm was mounted in front of 
the spectrometers to reject second order light at the detectors. The 1.3 mm diameter probe has 
a fiber connected to the light source and two other fibers each connected to a spectrometer. 
The center-to-center distance between the emitting and collecting fibers is 2.48 mm, where the 
tip of the probe has an angled bevel. All optical fibers are low-OH fibers of 200 microns core 
diameter. The spectrometers are controlled by custom-made software to acquire the data. 
Figure 1 depicts a schematic of the full setup. 
The system was calibrated prior to each measurement on the tissue samples. The 
calibration consisted of several steps. First, the detectors were cooled down to −40°C. Once 
the temperature was stable, a wavelength calibration was performed to assign a wavelength 
value to each pixel of both detectors, fitting a second order polynomial to a set of atomic lines 
from argon and mercury light sources with peaks at known wavelengths. The second steps 
consisted of calibrating the system with a white reflectance standard measurement to 
compensate for the spectral shape of the  light emitted by the lamp and the wavelength-
dependent sensitivity of the detectors. Subsequently, a background measurement was carried 
out. Each spectrum was acquired by measuring simultaneously with both spectrometers. The 
analyzed spectra corresponded to tissue measurements corrected for the spectral shape of the 
light source, and the spectral response of the detectors measured on a white standard reference 
measurement as described in detail in our previous studies [30,31]. 
The simultaneously acquired spectra in the 400-1100 nm range and in the near-infrared 
800-1700 nm range were combined to a single spectrum, using the 950-1000 nm range to 
scale the near-infrared spectrum to the visible spectrum. For the spectral analyses we have 
used the 500-1600 nm spectral range, where the 500 to 1000 nm and 1000 to 1600 nm 
correspond to the data collected with the silicon and InGaAs detectors, respectively [31]. 
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Fig. 1. Schematic of the optical setup and the design of the optical probe. 
2.3. Mathematical modeling of the diffuse optical spectra 
The measured diffuse optical spectra were fitted, using the method of Farrell et al. [29] where 
the reduced scattering coefficient ( )
,
s µλ , the absorption coefficient ( ) a µλ and the center-to-
center distance between the emitting and collecting fibers at the tip of the probe are input 
arguments for the model. The spectra were fitted over the wavelength range of 500-1600 nm, 
using a non-constrained linear least squares fitting algorithm. The validation of this method 
with the setup and optical probe described in section 2.2 was performed in our previous work 
based on an extensive phantom and in vivo animal studies [30,31]. Briefly, we demonstrated 
that the fiber distance separation that is used is large enough in order not to infringe the 
diffusion theory assumptions. An extensive phantom study with different absorption and 
reduced scattering properties was performed to investigate the robustness of the fit. It was also 
shown that the model is suitable to properly estimate chromophore concentrations 
independently from the reduced scattering profile which was varied by changing the particle 
size distribution in the phantoms. The confidence intervals of the estimated parameters that 
derive from the covariance matrix were also used to investigate the reliability of the fits from 
the phantom measurements. 
The wavelength dependant reduced scattering coefficient is expressed by a double power 
law 
  ( ) ( )
4
, -1
00
1    [ ],
b
s MR MR a cm
λλ
µλ ρ ρ
λλ
−−   
 =+−      
   (1) 
where the wavelength λ  is expressed in nm and is normalized to a wavelength value of  0 λ  = 
800 nm. The reduced scattering coefficient is expressed as the sum of a Mie and a Rayleigh 
scattering where  MR ρ  is the Mie-to-total reduced scattering fraction and b corresponds to the 
slope of the Mie reduced scattering. The total reduced scattering amplitude at  0 λ  is denoted a. 
We adopted the formulation of the absorption coefficient that is described in our previous 
study [31] where the absorption, due to chromophores present in the measured tissue, is 
expressed as 
  ( ) ( ) ( )
-1    []
Tissue Blood WL
a aa cm µ λµ λµλ = +    (2) 
where  ( )
Blood
a µλ   corresponds to the absorption by blood and  ( )
WL
a µλ   corresponds to 
absorption by water and lipid in the probed tissue. The blood related absorption coefficient is 
given by 
  ( ) ( ) ( ) ( ) ( )
2 -1
22 1    []
HbO Blood Hb
a Blood t a t a C SO SO c m µ λ λν µ λ µ λ  =+−     (3) 
where 
2 HbO
a µ  and 
Hb
a µ  are the absorption coefficient of oxygenated hemoglobin  2 HbO  and 
deoxygenated hemoglobin Hb, respectively. The parameter  Blood ν  corresponds to the blood 
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corresponds to the oxygen saturation of the blood in the probed volume. The factor C  is a 
wavelength dependant correction factor known as a pigment packaging factor [32] and is 
given by 
  ( )
( ) ( ) ( ) ( )
( ) ( ) ( )
2
2
22
22
1 exp 2 1
21
HbO Hb
ta t a
HbO Hb
ta t a
R SO SO
C
R SO SO
µ λ µλ
λ
µ λ µλ
 − − +−  =
 +− 
   (4) 
with  R  the average vessel radius expressed in cm; note however that its value is reported in 
microns throughout this paper. The absorption due to the presence of water and lipid in the 
measured tissue is defined as 
  ( ) ( ) ( ) ( )
2 -1 1    []
HO WL Lipid
a WL Lipid a Lipid a f f cm µλν µ λ µ λ  =+−     (5) 
with 
2 HO
a µ  and 
Lipid
a µ  being the absorption coefficient of water and lipid (density of 0.86 g/ml 
[31]), respectively. The parameters  WL ν  and  Lipid f  correspond to the total volume fraction of 
water and lipid in the tissue and the lipid fraction within this volume, respectively. Describing 
the absorption due to water and lipid as in Eq. (5) has the advantage that the covariance 
between  WL ν  and  Lipid f  is smaller compared to the sum of the absorption of water and lipid 
separately weighted by corresponding volume fractions [31]. However, throughout this paper 
WL ν  and  Lipid f  are converted to water and lipid fractions and reported as such because of their 
clinical relevance for interpretation. 
When inspecting the measured spectra, it was observed that there was a missing absorber 
in the visible wavelength range i.e. between 500 and 750 nm. The assumption was that bile 
would be the missing absorber in the fit model, since it is an endogenous compound which is 
abundant in liver [33]. Absorption by bile was included by incorporating it into Eq. (2) so that 
the total absorption is expressed as 
  ( ) ( ) ( )
-1    []
Total Tissue Bile
a a Bile a cm µ λ µ λνµ λ = +    (6) 
where  Bile ν  and 
Bile
a µ  are the volume fraction and absorption coefficient of bile, respectively. 
The absorption coefficient was determined by measuring bile freshly obtained from the 
gallbladder of two patients who underwent a cholecystectomy as part of the liver resection 
operation. The bile was poured in cuvettes of different thickness (1, 2, 5 and 10 mm) and the 
optical transmission was measured in a spectrophotograph (Lambda 900 Spectrometer, Perkin 
Elmer) with a resolution of 1 nm. The bile absorption is depicted in Fig. 2 (circle-marked 
curve) and it corresponds to the measured absorption coefficients from 300 to 1600 nm. In the 
near-infrared, the bile absorption is similar to the water absorption coefficient [33]. This is 
due to the fact that bile is mainly composed of water. In the visible, bile has a local maximum 
at 409 nm, a local minimum at 350 nm and a large absorption peak centered at 605 nm. 
Additionally,  Fig. 2  shows the absorption coefficient in a logarithmic scale of fully 
oxygenated hemoglobin [34], deoxygenated hemoglobin [34], lipid [30] and water [30] from 
400 to 1600 nm. 
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Fig. 2. Absorption coefficients of deoxygenated hemoglobin (solid line), oxygenated 
hemoglobin (dashed line), lipid (dashed-dotted line) and water (dotted line) from 400 to 1600 
nm .Absorption coefficient of bile (circle-marked line) from 300 to 1600 nm. The absorption 
coefficient axis is in a logarithmic scale. 
In the model, we have used the bile absorption coefficient as the measured bile absorption 
coefficient from which the water absorption coefficient was retrieved. Figure 3 depicts the 
normalized absorption coefficients of bile, oxygenated and deoxygenated hemoglobin starting 
from 500 nm (starting wavelength of the fit). Bile has a large absorption peak at 605 nm of 5.4 
cm
−1  and its value does not change more than 5% between 550 and 650 nm. This large 
absorption peak can significantly change the spectral shape in the visible range of a 
measurement where bile is present in the tissue. 
 
 
Fig. 3. Normalized absorption coefficients of deoxygenated hemoglobin (dashed line), 
oxygenated hemoglobin (dotted line), and bile (solid line) between 500 and 1000 nm. 
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Lipid f , and  Bile ν  are determined. For each of these fit parameters, the confidence intervals were 
computed from the square root of the diagonal of the covariance matrix for a critical value of 
0.05 [35]. A statistical F-test was performed to evaluate the improvement when bile is added 
to the model. The F-test is based on analyzing the difference between the sum-of-squares of 
the model with and without the bile absorption component. From the number of data points 
within the wavelength range where the fit was performed and the number of fit parameters for 
the models with and without the bile component, an F-ratio is computed from which a p-value 
can be extracted. If the p-value is smaller than the specific significance level chosen to be 
0.05, the model with the bile component leads to a better description of the measured spectra. 
Statistical comparison of the parameters estimated from the healthy and metastatic tumor 
measurements was performed, using the Kruskal-Wallis non-parametric test with significance 
determined by computed p-values [36]. 
3. Results 
3.1. Mathematical model applied to the healthy liver tissue measurements 
Figure 4 shows a measured spectrum from 500 to 1600 nm of a healthy liver sample (dotted 
line), the corresponding fit curve without the bile component added into the model (solid line) 
and the 95% confidence bounds (dashed lines) [37]. For the measurement shown in Fig. 4, the 
parameters and the corresponding confidence intervals obtained from the fit are  Blood ν  = 4.4 ± 
0.3%,  2 t SO = 22 ± 8%,  R  = 76 ± 13μm,  WL ν  = 91 ± 2%,  Lipid f  = 17 ± 2%, and a reduced 
scattering amplitude of 14.2 ± 0.3 cm
−1 at 800 nm with a Mie-to-total reduced scattering 
fraction of 19 ± 4%. When investigating the residual (χ
2 = 0.238) and the confidence bounds, 
a large deviation between the measurement and the fit curves was observed around the 
deoxygenated hemoglobin peak at 758 nm. 
 
Fig. 4. Reflectance measurement (dotted line) from a normal ex vivo tissue sample and its fit 
(solid line) without bile absorption coefficient implemented in the model and the corresponding 
95% confidence bound (dashed lines). The vertical dotted lines at 605, 757, 972 and 1211 nm 
correspond to the absorption peaks location of bile, deoxygenated hemoglobin, water and lipid, 
respectively. 
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nm significantly reduced while the confidence bounds narrowed towards the fit curve. The 
measurement curve in Fig. 5 is the same than the one depicted in Fig. 4 with a fit including the 
bile absorption coefficient in the model. For the measurement shown in Fig. 5, the estimated 
values and the corresponding confidence intervals are  Bile ν  = 3.9 ± 0.7%,  Blood ν  = 3.5 ± 0.3%, 
2 t SO = 37 ± 8%, R = 56 ± 13μm,  WL ν  = 93 ± 2%,  Lipid f  = 19 ± 1%, and a reduced scattering 
amplitude of 14.5 ± 0.3 cm
−1 at 800 nm with a Mie-to-total reduced scattering fraction of 25 ± 
7% were found. The residual decreased to a value of χ
2 = 0.206. In comparison to the outcome 
of the model without bile, the oxygen saturation level is higher, indicating that the bile 
absorption was compensated by deoxygenated hemoglobin. Similar results can be seen in 
Table 1  which shows comparison of the mean and standard deviation of the parameters 
obtained from all the spectra measured on the 14 normal human liver tissue samples. Based on 
the confidence intervals, the model with bile showed for each sample that the parameters were 
estimated more reliably compared to the model without bile. Another observation in Fig. 5 is 
that the 95% confidence bound is closer to the fit curve, especially in the wavelength range 
between 500 and 800 nm where a bile absorption peak is present. 
 
Fig. 5. Reflectance measurement (dotted line) from a normal ex vivo tissue sample and its fit 
(solid line) with bile absorption implemented in the model and the corresponding 95% 
confidence bound (dashed line). The vertical  dotted lines at 605, 757, 972 and 1211 nm 
correspond to absorption peaks location of bile, deoxygenated hemoglobin, water and lipid, 
respectively. 
In order to depict the imprint of bile absorption on the measured spectra, a forward 
calculation of the spectrum with the estimated parameters can be computed by setting the bile 
volume fraction to 0%. Figure 6 shows another example of a healthy liver spectrum and the 
corresponding fits where the estimated bile volume fraction is 10.4%. Additionally, the 
forward computation of the spectrum by using the estimated parameters as input arguments 
and setting the bile volume fraction to 0% is plotted and the area comprised between the 
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result from bile absorption. 
In order to mathematically evaluate whether bile is the missing absorber in the model, a 
statistical F-test was applied to all the data acquired at healthy sites in the liver [37]. P-values 
were computed from the F-ratios to evaluate if the model with bile absorption improved the 
fits. In total, 95% of the data have shown that the model including bile described best the 
measured spectra with a p-value below 0.05. 
 
Fig. 6. Tissue measurement from a normal tissue sample (dotted line) with an estimated bile 
volume fraction estimated from the fit (red solid line) of 10.4%. The colored area indicates the 
imprint of bile absorption obtained by comparison with a forward computation of the diffuse 
reflectance spectrum where the bile volume fraction is set to 0% (black solid line). 
Table 1. Mean and standard deviation of the estimated values of the physiological and 
morphological parameters of healthy liver tissues obtained from the fitting model without 
and with bile absorption coefficient 
Parameters  Fit without bile  Fit with bile
a 
Bile (%)  -  6.6 ± 4.5 
Blood volume fraction (%)  4.8 ± 0.3  3.4 ± 2.0 
Blood oxygenation level (%)  6 ± 8  8 ± 14 
Average vessel radius (microns)  67 ± 28  50 ± 22 
Water volume fraction (%)  77 ± 7  76 ± 7 
Lipid volume fraction (%)  17 ± 11  19 ± 11 
Reduced scattering at 800 nm (cm
−1)  17 ± 2  17 ± 3 
Mie slope  0.5 ± 0.3  1.0 ± 0.5 
Mie-to-total scattering fraction (%)  19 ± 10  37 ± 19 
aAccording to a statistical F-test with p<0.05, 95% of the data showed improvement on the 
fitting when bile is added to the model. 
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Figure 7 shows a typical spectrum (dotted line) from both healthy and metastatic tumor liver 
tissues with the corresponding fit curves (solid line) including bile. Major differences between 
the two typical spectra correlated with a difference in the estimated parameters. 
 
Fig. 7. Reflectance measurement of healthy and metastatic tumor liver tissues (dotted line) and 
their corresponding fits (solid line). 
From the typical metastatic tissue measurement depicted in Fig. 7, the estimated 
parameters and the corresponding confidence intervals are  Bile ν  = 0 ± 0%,  Blood ν  = 1.5 ± 0.1%, 
2 t SO = 3 ± 5%, R = 31 ± 3μm,  WL ν  = 101 ± 2%,  Lipid f  = 10 ± 1%, and a reduced scattering 
amplitude of 9.8 ± 0.3 cm
−1 at 800 nm with a Mie-to-total reduced scattering fraction of 76 ± 
4%. 
Table 2 summarizes all the median and standard deviations derived from the interquartiles 
of the various fit parameters for all the measurements performed in the fourteen samples of 
healthy and metastatic liver tissues. The advantage of reporting the median and the standard 
deviation derived from interquartiles instead of the mean and standard deviation is that the 
data  cannot be described by a parametric distribution, hence we used a non-parametric 
statistical Kruskal-Wallis test instead of a t-test to find which parameters show significant 
difference between the two types of tissue, as was also done in previous studies 
[10,12,13,19,20,22,24,25]. The blood oxygenation was not reported, due to the fact that the 
study was conducted on ex vivo samples. Therefore this parameter does not reflect the actual 
oxygenation level as it would be in vivo. According to the Kruskal-Wallis statistical test, the 
values that showed most significant differences between healthy and metastatic tissues with 
p<0.01 were bile, the reduced scattering amplitude and the water volume fraction. 
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estimated from ex vivo measurements performed on normal and metastatic tumor tissues 
in liver 
Parameters  Normal liver 
(14 samples) 
Metastatic tumor 
(14 samples) 
Bile (%)
a  5.5 ± 2.3  1.0 ± 1.1 
Blood volume fraction (%)  3.2 ± 1.6  0.8 ± 2.4 
Blood oxygenation level (%)  8 ± 14  45 ± 44 
Average vessel radius (microns)  53 ± 20  67 ± 82 
Water volume fraction (%)
a  76 ± 4  93 ± 17 
Lipid volume fraction (%)  16 ± 3  12 ± 6 
Reduced scattering at 800 nm (cm
−1) 
a  17 ± 3  10 ± 3 
Mie slope  1.2 ± 0.7  0.5 ± 0.5 
Mie-to-total scattering fraction (%)  44 ± 25  57 ± 15 
aIndicates significant differences with p<0.01 for the Kruskal-Wallis test. 
Figure 8 shows a picture of a tumor and the surrounding healthy liver tissue. It is visually 
clear that the tumor is less rich in blood than the healthy liver tissue. All the measured tumors 
were at least a centimeter in diameter and rather white in appearance. 
 
Fig. 8. Picture of a tumor surrounded by healthy liver tissue. The optical probe is directed 
towards the tumor site. 
4. Discussion 
A paucity of studies has investigated the absorption coefficient of bile. Maitland et al. [33] 
measured the absorption coefficient of bile from 350 to 2450 nm and stated that bile has its 
main absorption peaks at 400, 1450 and 1900 nm. The latter two most likely correspond to 
absorption due to the presence of water in bile, whereas the peak at 400 nm corresponds to an 
actual absorption peak of bile. After measuring the absorption coefficient of bile, we observed 
a broad absorption peak between 550 and 650 nm with a local maximum of 5.4 cm
−1 at 605 
nm. Our measurement also suggests that there is a higher absorption peak at 409 nm, whereas 
the maximum reported by Maitland et al. is at 400 nm [33]. The presented bile absorption 
coefficients in this paper can therefore be considered as an updated measurement of the one 
reported by Maitland et al. [33]. 
This study demonstrated the necessity to incorporate the bile absorption coefficient into 
the model when fitting spectroscopic measurements in liver tissue. In 95% of the measured 
healthy tissue data, including bile in the fitting model provided a better fit according to a 
statistical F-test. The fit parameters that were mainly altered when the bile was not added to 
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normal samples, the blood volume fraction decreased on average from 4.8 ± 1.7% to 3.4 ± 
2.0%, whereas no significant changes were observed for the oxygenation level of blood. 
Figure 2 and 3  illustrates a higher absorption for deoxygenated hemoglobin than for 
oxygenated hemoglobin between 550 and 750 nm. The main absorption of bile is between 
these wavelengths. The resulting fit model without bile compensates for the residual by 
overestimating the deoxygenated hemoglobin yielding higher blood volumes with unchanged 
oxygen saturation levels. Moreover, this discrepancy is observed between the measurement 
and the fit curves depicted at 758 nm in Fig. 4 where no bile was taken into account in the 
model. It is important to note that deoxygenated-hemoglobin has a distinct spectral absorption 
peak at 758 nm (cf. Fig. 2) resulting in an inflection point in the fits that is not present in the 
measured liver spectra. Furthermore, changes are observed in the Mie slope and Mie-to-total 
reduced scattering fractions, whereas the reduced scattering amplitude remains unchanged. 
Finally, no effects on the estimation of water and lipid fractions is seen when bile is not 
present in the model. This is expected since there are no overlapping absorption features 
between these two biological parameters. 
It is important to note that the bile that was used to measure its absorption coefficients 
comes from patients suffering from metastatic colorectal cancer. Therefore the pigmentation 
concentration in the bile can vary from one person to another, resulting in slightly different 
absorption coefficients; hence the presence of a significant residual around 800 nm when bile 
is added in the model (cf. Fig. 5). However, this is not the case in all patients. Another remark 
with respect to the residual is the small deviation between the measurement and the fits 
around 1211 nm which is most probably due to changes in water absorption coefficients with 
temperature. Indeed, the tissue measurements were performed ex vivo after resection, and 
hence the temperature of the samples decreased from body temperature down to the room 
ambient temperature when brought to the pathology department. We have shown elsewhere 
[30] that water absorption coefficient is temperature dependant and that it is prone to 
significant variation in absorption in the vicinity of 1200 nm, hence the small residual around 
this wavelength. 
The analysis of the diffuse optical spectra showed significant differences according to the 
Kruskal-Wallis non-parametric test with a critical value of 0.01 for bile and water volume 
fractions, as well as the reduced scattering amplitude and the oxygenation saturation of blood. 
The study by Kitai et al. [16] measured the optical properties before and after clamping 
the left branches of the hepatic pedicle, including the portal vein and hepatic artery, during 60 
minutes. Their study showed that the oxygenation level in blood equals 75% just before 
clamping the vessels and drops down to 8% one hour after clamping. The median oxygenation 
values in the healthy tissues and tumors presented in Table 2 are 8% and 45%, respectively. In 
our study, the blood vessels of the resected specimens were clamped up to one hour before the 
resection was completed and the samples were transported within a time frame of two hours 
after resection to the pathology department. Therefore, there was no more blood flow and 
perfusion to the liver tissue in the ex vivo samples yielding to a decrease in oxygenation levels 
when the samples were delivered for measurements. It  is therefore difficult to draw any 
conclusions by comparing the estimated oxygenation levels in healthy tissues and the tumors 
measured ex vivo. 
The reduced scattering amplitude and the bile volume fraction showed the most significant 
differences (p<0.0001) between healthy and metastatic liver tissues. As shown in Table 2, 
healthy tissue has more than five times more bile than tumors whereas the reduced scattering 
amplitude is almost twice as high. Healthy liver tissue is mainly constituted of hepatocytes 
which are cells that are arranged as very thin plates separated by fine vascular sinusoids where 
blood flows; allowing perfusion of the bile throughout the liver [38]. In the tumor, this 
structure is lost, causing a different perfusion of the bile and an alteration of the cell structures 
yielding to a different light scattering. This observation is consistent with the fact that the 
tumors in liver are metastases of colorectal cancer with different structural composition. The 
tumor consists therefore of abnormal colorectal tissue cells embedded in collagenous cellular 
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stroma. Therefore, hardly any bile is expected in the tumor cells from colorectal origin. 
The reduced scattering amplitude is 1.7 times higher in healthy tissue than in tumors. 
Germer et al. measured the absorption coefficient, scattering and anisotropy of human liver 
tissues and colorectal liver metastases in vitro at 850, 980 and 1064 nm [39]. They found that 
scattering in human liver tissues is in average 1.7 times higher than in the metastases tissues. 
However, the large difference in anisotropy yields to reduced scattering of 9.5 and 11 cm
−1 at 
800 nm (extrapolated values) for normal and metastatic liver  tissue, respectively [39]. 
Therefore, the reduced scattering amplitude of the metastatic tumor reported in Table 2 is very 
comparable to the value reported in ref [39], whereas the value in healthy liver tissue is much 
higher. 
The water volume fraction showed significant difference between both types of tissue with 
higher water content in tumor. There is a multitude of factors that could explain this 
observation. In particular, the fact that water is attracted to necrotic tissue which is also 
abundantly present in most colorectal liver metastases, the high water content of collagenous 
stroma in general, and tumor induced stroma could play a role. 
From Table 2, one can observe a low Mie scattering contribution in liver compared to 
other organs. The reported Mie-to-total scattering fraction in healthy tissue and tumors are 
44% and 57%, respectively. Optical properties such as the absorption coefficient, scattering 
coefficient and anisotropy of porcine liver were measured with a double integrating sphere 
setup by Fritz et al. [40] where it is clearly shown that the anisotropy of liver tissue steeply 
increases from 0.75 to 0.9 between 400 and 600 nm and is constant at a value of 0.93 beyond 
600 nm up to 1600 nm. By applying the double power law for reduced scattering as expressed 
in  Eq. (1)  to the data of Fritz et al.  up to 1600 nm, the Mie-to-total reduced scattering 
contribution is as low as 59% which is comparable to the values reported in Table 2. This is a 
result of the high gradient of the anisotropy below 600 nm. Rayleigh scattering occurs due to 
the interaction of light with sub-micron structures, such as thin fibers, in tissue and it was 
proven that it is necessary to include a Rayleigh term in the reduced scattering model beyond 
500 nm [41]. Liver is very  rich in sub-micron reticular fibers in the perisinusoidal space 
separating hepatocytes from sinusoids, likely yielding high Rayleigh scattering [38]. 
Table 2 reports a median value of blood volume fraction in healthy and metastatic tissue of 
3.2% and 0.8%, respectively. However, despite this large difference, there is statistically no 
significant difference (p<0.05) between the two types of tissue because the standard deviation 
for tumor tissue is very large. The reason is that in two of the fourteen tumor samples, which 
were large necrotic samples, high amounts of blood were present. Indeed it is known that most 
tumors have a vascular network of higher density than most normal tissues. However, the 
opposite is true for colorectal liver metastases, as normal liver tissue is extremely well 
vascularized to fulfill its many functions related to metabolism, detoxification, bile 
production, etc. The absorption coefficient of the human liver measurements in Ref. [39] was 
found to be higher in the liver than in the metastases for the wavelengths of interest which in 
fact means that more blood is present in healthy liver tissue than in metastatic tumors which 
corroborates with the estimated blood volume fraction in Table 2. 
Given the distance between the emitting and collecting fibers, the amount of light that is 
collected below 600 nm is in some cases close to the noise level because of the high blood 
amount (above roughly 5%) in the liver. The high amount of blood causes a decrease in the 
amount of light that is collected. In order to enhance the reliability of the estimated parameters 
of the blood and bile, one could measure below 500 nm where additional absorption peaks of 
these chromophores exist (cf. Fig. 2) by using a smaller distance separation between the 
emitting and collecting fibers. 
5. Conclusion 
In conclusion, this paper presents the first study in which bile, water and lipid are included in 
addition to oxygenated and deoxygenated hemoglobin in the discrimination between healthy 
and metastatic tumors tissues in human liver with diffuse optical spectroscopy. The absorption 
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concentration of this chromophore in the liver. We have demonstrated that bile should be 
included when analyzing diffuse optical spectroscopy data, because of its presence in the liver 
bile ducts. Our results illustrate that discrimination between healthy and metastatic liver 
cancer tissues seems possible based on the estimated bile volume fraction and reduced 
scattering amplitude obtained from diffuse optical spectra measured on both types of tissue. 
Compared to healthy tissue, tumors have around five and two times lower bile and reduced 
scattering amplitude values, respectively. This method can also be applied during real-time 
intra-operative needle localization and ablation monitoring to improve ablation efficacy and 
hence disease-free survival. 
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